GENEWIZ is fully committed to advancing research around the novel coronavirus (2019-nCoV/SARS-CoV-2) outbreak. Our global presence, state-of-the-art facilities, and highly qualified scientific team, allows us to deliver with unparalleled quality and excellence. GENEWIZ’s unique DNA sequencing and synthesis solutions help research institutions around the world to better understand this pandemic virus.

GS icon

Gene Synthesis

De novo gene synthesis technologies enable the development and optimization of antigen-presenting viral genes for safe and rapid vaccine development. GENEWIZ’s synthetic DNA solutions can also be utilized to rapidly produce standard/controls for the development of coronavirus diagnostic assays.






Learn More


Oligo-Flex Synthesis


Scientists can now order primers and probes approved by the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and Chinese government for rapid identification of the virus.

Please see the available list of primers and probes here. HPLC purified COVID-19 primers and probes are available for direct order through our e-commerce platform. Note, all primers and probes are Research Use Only (RUO).


Learn More




Next Generation Sequencing

NGS continues to play an indispensable role in characterizing and understanding the rapid spread of the coronavirus across the globe. Technologies such as whole genome sequencing and targeted amplicon sequencing can help discover, identify, and monitor pathogenic sequences. 

GENEWIZ’s NGS service portfolio is uniquely positioned to help you identify and uncover known and emerging viruses. 


Learn More


PCR and Sanger Services Icon

PCR + Sanger Services

GENEWIZ’s PCR + Sanger workflows provide streamlined services from extraction to data analysis. These assays can facilitate the identification of viral strains, as well as characterize cell lines for vaccine development, at the RUO, GLP, and CLIA service levels.




Learn More



Sanger Services icon

Sanger Sequencing

GENEWIZ’s award-winning Sanger sequencing services are crucial for advancing COVID-19 research and vaccine development from viral strain identification to antigen sequence verification at the RUO, GLP, and CLIA service levels.



Learn More






plasmid-prep-overview icon_110x210

Plasmid DNA Prep

GENEWIZ’s plasmid preparation services enable rapid scale-up of viral genes to support therapeutic research and development of a COVID-19 vaccination.




Learn More






  1. US Centers for Disease Control and Prevention. (2020, February 4). Real-time RT-PCR panel for detection 2019-novel coronavirus.
  2. Author Unknown. (2020, January 17). Diagnostic detection of 2019-nCoV by real-time RT-PCR.
  3. National Institute For Viral Disease Control and Prevention. (2020, January 21). Specific primers and probes for detection 2019 novel coronavirus.

Additional information can be found at